1. Home
  2. CRDF vs SBT Comparison

CRDF vs SBT Comparison

Compare CRDF & SBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDF
  • SBT
  • Stock Information
  • Founded
  • CRDF 1999
  • SBT 1984
  • Country
  • CRDF United States
  • SBT United States
  • Employees
  • CRDF N/A
  • SBT N/A
  • Industry
  • CRDF Biotechnology: Biological Products (No Diagnostic Substances)
  • SBT Savings Institutions
  • Sector
  • CRDF Health Care
  • SBT Finance
  • Exchange
  • CRDF Nasdaq
  • SBT Nasdaq
  • Market Cap
  • CRDF 288.7M
  • SBT 249.0M
  • IPO Year
  • CRDF N/A
  • SBT 2017
  • Fundamental
  • Price
  • CRDF $4.75
  • SBT $4.61
  • Analyst Decision
  • CRDF Strong Buy
  • SBT
  • Analyst Count
  • CRDF 3
  • SBT 0
  • Target Price
  • CRDF $10.33
  • SBT N/A
  • AVG Volume (30 Days)
  • CRDF 971.7K
  • SBT 17.2K
  • Earning Date
  • CRDF 02-27-2025
  • SBT 01-30-2025
  • Dividend Yield
  • CRDF N/A
  • SBT N/A
  • EPS Growth
  • CRDF N/A
  • SBT N/A
  • EPS
  • CRDF N/A
  • SBT 0.04
  • Revenue
  • CRDF $688,000.00
  • SBT $66,063,000.00
  • Revenue This Year
  • CRDF $25.03
  • SBT N/A
  • Revenue Next Year
  • CRDF N/A
  • SBT N/A
  • P/E Ratio
  • CRDF N/A
  • SBT $115.25
  • Revenue Growth
  • CRDF 49.57
  • SBT N/A
  • 52 Week Low
  • CRDF $1.65
  • SBT $4.40
  • 52 Week High
  • CRDF $6.42
  • SBT $5.97
  • Technical
  • Relative Strength Index (RSI)
  • CRDF 62.77
  • SBT 39.41
  • Support Level
  • CRDF $4.12
  • SBT $4.67
  • Resistance Level
  • CRDF $4.38
  • SBT $4.75
  • Average True Range (ATR)
  • CRDF 0.38
  • SBT 0.07
  • MACD
  • CRDF 0.04
  • SBT -0.01
  • Stochastic Oscillator
  • CRDF 80.17
  • SBT 0.00

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").

About SBT Sterling Bancorp Inc.

Sterling Bancorp Inc is a unitary thrift holding company. Its primary business is the operation of its wholly-owned subsidiary, Sterling Bank, through which it offers a range of loan products to the residential and commercial markets, as well as retail banking services. The products and services offered by the bank include saving and current accounts, demand and term deposits, payment cards, trade finance, fund transfer, treasury and cash management. It provides services such as construction loans, residential real estate, commercial real estate, commercial lines of credit and other consumer loans.

Share on Social Networks: